Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.06 | -1.44 |
| PEG Ratio (TTM) | 0.00 | 3.67 |
| P/S Ratio (TTM) | 0.01 | 1.38 |
| P/B Ratio (TTM) | 0.04 | 5.16 |
| P/FCF Ratio (TTM) | 0.06 | 2.18 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.83 |
| Price to 5YR AVG FCF Ratio | N/A | 21.03 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -18.44% | 5.00% |
| ROE (TTM) | -47.55% | 7.26% |
| Net Profit Margin (TTM) | -18.92% | 4.81% |
| ROIC 5YR AVG | N/A | 13.99% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -106.07% | 17.78% | N/A |
| Revenue | -7.87% | 4.63% | N/A |
| Net Income | -106.99% | 17.85% | N/A |
| Cash Flow | 981.01% | 12.78% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | 1.98 |
| Quick Ratio (TTM) | 0.21 | 1.18 |
| D/E Ratio (TTM) | 1.19 | 1.95 |
| Interest Coverage (TTM) | -2.69 | 10.93 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 0.87 | 3.54 |
| LTL to 5YR AVG FCF | N/A | 5.72 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.29% |